Philip Morris International stock has delivered a very strong 143.6% return over the past 5 years, and with the current valuation screens suggesting the shares are about fairly priced, the key tension for investors is whether that performance already reflects most of the intrinsic value suggested by the Discounted Cash Flow (DCF) work.

• Over 5 years, Philip Morris International has returned 143.6%, which puts the recent share price near a level where it no longer looks obviously cheap.
• Growth in smoke free products can support expectations for future cash flows, while a reduced profit outlook and global uncertainties may limit how much investors are willing to pay for that growth.
• On Simply Wall St's broader valuation checks, Philip Morris International scores 1 out of 6, which leans more toward expensive than a clear bargain.

The issue now is whether Philip Morris International's recent run and fairly valued DCF estimate leave enough potential upside to justify the current price.

Does Philip Morris International Look Fairly Valued on Cash Flow?

The Discounted Cash Flow (DCF) method estimates what Philip Morris International might be worth based on the cash it is expected to generate for shareholders. The model uses latest twelve month free cash flow of about $10.6b as a starting point and assumes cash flows grow from this base rather than relying on a sharp rebound or steep decline. On these assumptions, the DCF points to an intrinsic value of about $202 per share in $.

Set against the current share price, that implies the stock trades at roughly a 4.5% discount to this intrinsic value estimate, so Philip Morris International screens as only modestly undervalued rather than a clear outlier. The recent update where Philip Morris International beat Q2 expectations but trimmed its full year profit outlook helps explain why the market is not assigning a larger premium even though the DCF supports a slightly higher value.

On this DCF view, Philip Morris International looks about fairly valued with a slight tilt toward being undervalued.

Philip Morris International is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Where Does Philip Morris International Sit on Earnings?

The P/E ratio is a useful cross check for Philip Morris International because earnings remain a key anchor for how investors look at the stock. Philip Morris International currently trades on a P/E of about 27.7x, which is well above the Tobacco industry average of roughly 11.5x and also above the broader peer group average of about 19.0x.

On Simply Wall St's fair multiple framework, which tries to reflect factors such as the company's size, margins and risk profile, Philip Morris International screens with a fair P/E of around 25.9x. That is only slightly below the current 27.7x, which suggests the market is pricing the shares close to what this model flags as a reasonable range rather than assigning a clear premium or discount.

Overall, the P/E checks suggest Philip Morris International is trading at roughly a fair valuation on earnings.

The Philip Morris International Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Philip Morris International pick up where the valuation checks leave off by spelling out which assumptions about Philip Morris International's future growth, margins and earnings would need to hold for the stock to be worth meaningfully more or less than today's price, and they sit on the company's Community page. Rather than relying on a single multiple or DCF figure, each narrative lays out the key inputs behind its fair value view so you can compare those expectations with actual results over time.

Community views on Philip Morris International sit wide apart, with one side focused on the smoke free shift and the other on regulatory and execution risks.

Bull case: roughly fairly valued

"The accelerating global adoption of smoke-free alternatives, driven by increasing health awareness and regulatory moves away from combustibles, is fueling strong double-digit volume and margin growth in PMI's IQOS, ZYN, and VEEV platforms…"

Bear case: 14% overvalued

"Extensive capital expenditures and R&D outlays to maintain leadership in smoke-free products, such as continued investments in IQOS, ZYN, and VEEV capacity and technology, expose the company to significant margin compression and earnings downside if regulatory approvals are delayed or consumer adoption falls short in nascent markets…"

Do you think there's more to the story for Philip Morris International? Head over to our Community to see what others are saying!

The Bottom Line

For Philip Morris International, the Discounted Cash Flow (DCF) work points to an intrinsic value only modestly above the current price, while the P/E checks also line up close to what looks like an about right multiple. That sits alongside a low broader value score, which hints that the supporting valuation signals are not especially strong despite the small DCF discount. From here, the crux for investors is whether smoke free products deliver enough dependable cash flow and earnings to support today’s valuation without leaving the stock looking exposed if execution or regulation disappoint.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.